BioSpace News Archive

Recognized for Taking on Challenge of Transformation to New Business Models by Integrating Management and Ict Strategies

One of the criticisms of the biopharma industry—at least in the context of drug pricing—is how much the industry as a whole spends on lobbyists. For example, last year, PhRMA, the industry lobbying group, spent more than $27.5 million on its lobbying activities.

Scientists from the Agency for Science, Technology and Research’s (A*STAR), Genome Institute of Singapore (GIS), together with scientists from Duke-NUS Medical School and A*STAR’s Bioinformatics Institute (BII), have mapped out the structures of four dengue and four Zika viruses.

EpiCypher® announced the signing of an agreement with Thermo Fisher Scientific, the world leader in servicing science, to provide co-exclusive use of EpiCypher’s SNAP-ChIP® technology.

The project company Belina is running an innovative project in early phase and is developing a product for treatment of breast cancer.

BioCity, a pioneering life science incubator and business collective, today announced investment in Deep Branch Biotechnology, a Nottingham-based carbon recycling start-up, developing technology that transforms polluters into producers.

GT Biopharma, Inc announced its Tri-Specific Killer Engager can target HIV infected cells in University of Minnesota’s preclinical testing.

Acerus Pharmaceuticals Corporation announced that Edward Gudaitis, President and Chief Executive Officer of Acerus, is scheduled to present an overview of the company at the Bloom Burton & Co. Healthcare Investor Conference.

Industry leaders to discuss the impact of advanced innovation on commercial models and driving improved patient outcomes

Arrowhead Pharmaceuticals Inc. announced that it has begun dosing in a new triple combination cohort (cohort 12) that includes JNJ-3989 (formerly ARO-HBV) and additional undisclosed agents selected by Janssen Pharmaceuticals, Inc. in its ongoing Phase 1/2 study (AROHBV1001) in patients with chronic hepatitis B virus (HBV).